+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Biogen Inc. - logo

Founded in 1978 Biogen Inc is a global biotechnology company with its headquarters in Cambridge, Massachusetts. In 2003 Biogen merged with Idec Pharmaceuticals to create Biogen Idec and acquired Syntonix Pharmaceuticals in 2007. In 2015 the company returned to its original name Biogen Inc and acquired Convergence Pharmaceuticals. Biogen focuses on drug discovery for a range of conditions including neuropathic pain, hemophilia, organ failure, neuromuscular disorders and oncology. Their product portfolio includes Rituxan, Avonex, Tecfidera and Eloctate.

From
From
From
From
From
Argentina Anti-Rheumatic Drug Market - Forecasts from 2022 to 2027 - Product Thumbnail Image

Argentina Anti-Rheumatic Drug Market - Forecasts from 2022 to 2027

  • Report
  • October 2022
  • 73 Pages
  • Argentina
From
Canada Anti-Rheumatic Drug Market - Forecasts from 2022 to 2027 - Product Thumbnail Image

Canada Anti-Rheumatic Drug Market - Forecasts from 2022 to 2027

  • Report
  • September 2022
  • 77 Pages
  • Canada
From
RNA Targeting Small Molecule Drug Discovery Market Report 2025 - Product Thumbnail Image

RNA Targeting Small Molecule Drug Discovery Market Report 2025

  • Report
  • February 2025
  • 200 Pages
  • Global
From
Loading Indicator